000			01355 a2200373 4500
005			20250516063813.0
264		0	_c20120606
008			201206s 0 0 eng d
022			_a1873-4111
024	7		_a10.1016/j.maturitas.2011.10.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aAspray, Terry J
245	0	0	_aTreatment of osteoporosis in women intolerant of oral bisphosphonates. _h[electronic resource]
260			_bMaturitas _cJan 2012
300			_a76-8 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aBone Density Conservation Agents _xadministration & dosage
650	0	4	_aDenosumab
650	0	4	_aDiphosphonates _xadministration & dosage
650	0	4	_aDrug Administration Routes
650	0	4	_aFemale
650	0	4	_aFractures, Bone _xprevention & control
650	0	4	_aHumans
650	0	4	_aKidney _xdrug effects
650	0	4	_aOsteoporosis _xdrug therapy
650	0	4	_aParathyroid Hormone _xtherapeutic use
650	0	4	_aPatient Compliance
650	0	4	_aVitamin D Deficiency _xcomplications
700	1		_aFrancis, Roger M
773	0		_tMaturitas _gvol. 71 _gno. 1 _gp. 76-8
856	4	0	_uhttps://doi.org/10.1016/j.maturitas.2011.10.005 _zAvailable from publisher's website
999			_c21307778 _d21307778